{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T13:49:31Z","timestamp":1707572971282},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2 diabetes mellitus (T2DM) and diminished myocardial perfusion increase the risk of heart failure (HF) and\/or all-cause mortality during 6-year follow up following primary percutaneous coronary intervention (pPCI) for ST elevation myocardial infarction (STEMI). The aim of the present study was to evaluate the impact of myocardial perfusion on infarct size and left ventricular ejection fraction (LVEF) in patients with T2DM and STEMI treated with pPCI. This is an ancillary analysis of an observational cohort study of T2DM patients with STEMI. We enrolled 406 patients with STEMI, including 104 with T2DM. Myocardial perfusion was assessed with the Quantitative Myocardial Blush Evaluator (QUBE) and infarct size with the creatine kinase myocardial band (CK-MB) maximal activity and troponin area under the curve. LVEF was measured with biplane echocardiography using Simpson\u2019s method at admission and hospital discharge. Analysis of covariance was used for modeling the association between myocardial perfusion, infarct size and left ventricular systolic function. Patients with T2DM and diminished perfusion (QUBE below median) had the highest CK-MB maximal activity (252.7\u2009\u00b1\u2009307.2\u00a0IU\/L, P\u2009&lt;\u20090.01) along with the lowest LVEF (40.6\u2009\u00b1\u200910.0, P\u2009&lt;\u20090.001). Older age (p\u2009=\u20090.001), QuBE below median (p\u2009=\u20090.026), and maximal CK-MB activity (p\u2009&lt;\u20090.001) were independent predictors of LVEF. Diminished myocardial perfusion assessed by QuBE predicts significantly larger enzymatic infarct size and lower LVEF among patients with STEMI treated with pPCI, regardless of diabetes status.<\/jats:p>","DOI":"10.1038\/s41598-022-24855-6","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:04:38Z","timestamp":1672938278000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status"],"prefix":"10.1038","volume":"13","author":[{"given":"Katarzyna","family":"Nabrdalik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Irlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kwiendacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Radzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Pigo\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"M\u0142y\u0144czak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Gumprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Nowalany-Kozielska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"24855_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2018.04.017","volume":"264","author":"M Reindl","year":"2018","unstructured":"Reindl, M. et al. ACEF score adapted to ST-elevation myocardial infarction patients: The ACEF-STEMI score. Int. J. Cardiol. 264, 18\u201324 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"24855_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/eurheartj\/ehn125","volume":"29","author":"SJ Brener","year":"2008","unstructured":"Brener, S. J. et al. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur. Heart J. 29(9), 1127\u20131135 (2008).","journal-title":"Eur. Heart J."},{"issue":"4","key":"24855_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2337\/dc12-1507","volume":"36","author":"G De Luca","year":"2013","unstructured":"De Luca, G. et al. Impact of diabetes on long-term outcome after primary angioplasty. Diabetes Care 36(4), 1020\u20131025 (2013).","journal-title":"Diabetes Care"},{"issue":"11","key":"24855_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ehj.2004.04.001","volume":"25","author":"JR Timmer","year":"2004","unstructured":"Timmer, J. R. et al. Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur. Heart J. 25(11), 926\u2013931 (2004).","journal-title":"Eur. Heart J."},{"issue":"2","key":"24855_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39(2), 119\u2013177 (2018).","journal-title":"Eur. Heart J."},{"issue":"13","key":"24855_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archinte.167.13.1353","volume":"167","author":"JR Timmer","year":"2007","unstructured":"Timmer, J. R. et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: Results from the primary coronary angioplasty vs thrombolysis-2 trial. Arch. Intern. Med. 167(13), 1353\u20131359 (2007).","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"24855_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","volume":"101","author":"CM Gibson","year":"2000","unstructured":"Gibson, C. M. et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2), 125\u2013130 (2000).","journal-title":"Circulation"},{"issue":"23","key":"24855_CR8","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","volume":"97","author":"AW van\u2019t Hof","year":"1998","unstructured":"van\u2019t Hof, A. W. et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade: Zwolle Myocardial Infarction Study Group. Circulation 97(23), 2302\u20132306 (1998).","journal-title":"Circulation"},{"issue":"2","key":"24855_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","volume":"93","author":"I Hiroshi","year":"1996","unstructured":"Hiroshi, I. et al. Clinical implications of the \u2018no reflow\u2019 phenomenon. Circulation 93(2), 223\u2013228 (1996).","journal-title":"Circulation"},{"issue":"13","key":"24855_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","volume":"37","author":"G Niccoli","year":"2016","unstructured":"Niccoli, G., Scalone, G., Lerman, A. & Crea, F. Coronary microvascular obstruction in acute myocardial infarction. Eur. Heart J. 37(13), 1024\u20131033 (2016).","journal-title":"Eur. Heart J."},{"issue":"2","key":"24855_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.amjcard.2007.02.080","volume":"100","author":"SP Marso","year":"2007","unstructured":"Marso, S. P. et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD trial). Am. J. Cardiol. 100(2), 206\u2013210 (2007).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"24855_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2009.03.042","volume":"207","author":"G De Luca","year":"2009","unstructured":"De Luca, G. et al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb\u2013IIIa inhibitors. Atherosclerosis 207(1), 181\u2013185 (2009).","journal-title":"Atherosclerosis"},{"issue":"4","key":"24855_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jacc.2004.10.054","volume":"45","author":"A Prasad","year":"2005","unstructured":"Prasad, A. et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 45(4), 508\u2013514 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"24855_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/CIRCULATIONAHA.104.495127","volume":"112","author":"S Roldano","year":"2005","unstructured":"Roldano, S., Christian, N., Vigili, D. K. S., Antonio, T. & Angelo, A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 112(2), 179\u2013184 (2005).","journal-title":"Circulation"},{"key":"24855_CR15","first-page":"25","volume":"10","author":"A Tomasik","year":"2020","unstructured":"Tomasik, A. et al. Effect of diabetes mellitus and left ventricular perfusion on frequency of development of heart failure and\/or all-cause mortality late after acute myocardial infarction. Am. J. Cardiol. 10, 25\u201332 (2020).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"24855_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","volume":"39","author":"RJ Burns","year":"2002","unstructured":"Burns, R. J. et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J. Am. Coll. Cardiol. 39(1), 30\u201336 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"24855_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/hrt.2007.122622","volume":"94","author":"E Wu","year":"2008","unstructured":"Wu, E. et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart 94(6), 730\u2013736 (2008).","journal-title":"Heart"},{"issue":"5","key":"24855_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/eurheartj\/ehn542","volume":"30","author":"M Vogelzang","year":"2009","unstructured":"Vogelzang, M. et al. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: A substudy from the TAPAS trial. Eur. Heart J. 30(5), 594\u2013599 (2009).","journal-title":"Eur. Heart J."},{"issue":"4","key":"24855_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5603\/CJ.a2017.0129","volume":"26","author":"A Tomasik","year":"2019","unstructured":"Tomasik, A. et al. Quantitative myocardial blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-segment elevation myocardial infarction: Proof of concept study. Cardiol. J. 26(4), 322\u2013332 (2019).","journal-title":"Cardiol. J."},{"issue":"7","key":"24855_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00259-004-1482-4","volume":"31","author":"R Sciagr\u00e0","year":"2004","unstructured":"Sciagr\u00e0, R. et al. Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention. Eur. J. Nucl. Med. Mol. Imaging. 31(7), 969\u2013974 (2004).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"issue":"4","key":"24855_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s12350-021-02533-w","volume":"28","author":"R Assante","year":"2021","unstructured":"Assante, R. et al. Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging. J. Nucl. Cardiol. 28(4), 1222\u20131233 (2021).","journal-title":"J. Nucl. Cardiol."},{"issue":"16","key":"24855_CR22","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1161\/01.CIR.0000065221.06430.ED","volume":"107","author":"JPS Henriques","year":"2003","unstructured":"Henriques, J. P. S. et al. Angiographic assessment of reperfusion in acute myocardial infarction by Myocardial Blush Grade. Circulation 107(16), 2115\u20132119 (2003).","journal-title":"Circulation"},{"issue":"2","key":"24855_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijcard.2006.04.082","volume":"117","author":"G De Luca","year":"2007","unstructured":"De Luca, G. et al. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty. Int. J. Cardiol. 117(2), 232\u2013237 (2007).","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"24855_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ahj.2011.04.014","volume":"162","author":"I Porto","year":"2011","unstructured":"Porto, I. et al. Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: Comparison with cardiovascular magnetic resonance. Am. Heart J. 162(2), 372-381.e2 (2011).","journal-title":"Am. Heart J."},{"issue":"8","key":"24855_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.amjcard.2011.11.046","volume":"109","author":"SJ Brener","year":"2012","unstructured":"Brener, S. J., Mehran, R., Dressler, O., Cristea, E. & Stone, G. W. Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). Am. J. Cardiol. 109(8), 1111\u20131116 (2012).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"24855_CR26","first-page":"25","volume":"18","author":"S Rasoul","year":"2010","unstructured":"Rasoul, S., Dambrink, J. H. E., Breeman, A., Elvan, A. & van\u2019t Hof, A. W. J. The relation between myocardial blush grade and myocardial contrast echocardiography: which one is a better predictor of myocardial damage?. Neth Heart J. 18(1), 25\u201330 (2010).","journal-title":"Neth Heart J."},{"issue":"20","key":"24855_CR27","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1001\/archinte.164.20.2273","volume":"164","author":"AM Murcia","year":"2004","unstructured":"Murcia, A. M. et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch. Intern. Med. 164(20), 2273\u20132279 (2004).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"24855_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ahj.2007.06.020","volume":"154","author":"JR Alegria","year":"2007","unstructured":"Alegria, J. R., Miller, T. D., Gibbons, R. J., Yi, Q. L. & Yusuf, S. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am. Heart J. 154(4), 743\u2013750 (2007).","journal-title":"Am. Heart J."},{"issue":"3","key":"24855_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ihj.2015.09.026","volume":"68","author":"F Ali","year":"2016","unstructured":"Ali, F., Naqvi, S. A. S., Bismillah, M. & Wajid, N. Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients. Indian Heart J. 68(3), 325\u2013331 (2016).","journal-title":"Indian Heart J."},{"issue":"12","key":"24855_CR30","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/dom.13002","volume":"19","author":"SJ Reinstadler","year":"2017","unstructured":"Reinstadler, S. J. et al. Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction. Diabetes Obes. Metab. 19(12), 1706\u20131713 (2017).","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"24855_CR31","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ccd.25203","volume":"83","author":"EA Sanidas","year":"2014","unstructured":"Sanidas, E. A. et al. Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE-AMI study. Catheter. Cardiovasc. Interv. 83(5), 704\u2013710 (2014).","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"24855_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.amjcard.2013.10.040","volume":"113","author":"MI Zia","year":"2014","unstructured":"Zia, M. I. et al. Comparison of the frequencies of myocardial edema determined by cardiac magnetic resonance in diabetic versus nondiabetic patients having percutaneous coronary intervention for ST elevation myocardial infarction. Am. J. Cardiol. 113(4), 607\u2013612 (2014).","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"24855_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/CIRCIMAGING.112.974998","volume":"5","author":"I Eitel","year":"2012","unstructured":"Eitel, I. et al. Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction. Circ. Cardiovasc. Imaging. 5(6), 708\u2013718 (2012).","journal-title":"Circ. Cardiovasc. Imaging."},{"issue":"11","key":"24855_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/eurjhf\/hfq179","volume":"12","author":"AM Shah","year":"2010","unstructured":"Shah, A. M. et al. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur. J. Heart Fail. 12(11), 1229\u20131237 (2010).","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"24855_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/eurjhf\/hfr125","volume":"14","author":"AM Shah","year":"2012","unstructured":"Shah, A. M. et al. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur. J. Heart Fail. 14(2), 185\u2013192 (2012).","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"24855_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jacc.2008.04.006","volume":"52","author":"R Nijveldt","year":"2008","unstructured":"Nijveldt, R. et al. Functional recovery after acute myocardial infarction. J. Am. Coll. Cardiol. 52(3), 181\u2013189 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"24855_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"Noyan-Ashraf, M. H. et al. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58(4), 975\u2013983 (2009).","journal-title":"Diabetes"},{"issue":"1","key":"24855_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","volume":"4","author":"G LimVen","year":"2019","unstructured":"LimVen, G. et al. SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart. JACC Basic Transl. Sci. 4(1), 15\u201326 (2019).","journal-title":"JACC Basic Transl. Sci."},{"issue":"12","key":"24855_CR39","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","volume":"33","author":"J L\u00f8nborg","year":"2012","unstructured":"L\u00f8nborg, J. et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur. Heart J. 33(12), 1491\u20131499 (2012).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24855-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24855-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:14:24Z","timestamp":1672938864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24855-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["24855"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24855-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"assertion":[{"value":"17 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}